All Insights
Showing 1 - 12 of 189
Tax
Spring Budget 2023 | What tax measures were announced?
A budget for growth but no cuts in tax rates
16/03/2023
Life Sciences and Healthcare
Spring Budget 2023 | UK chancellor announces new regulatory model for medicines and medical technologies
Move raises the question of whether regulatory framework for medicines and medical devices will diverge from the EU model in
16/03/2023
Regulatory and compliance
Consultation opens on proposed revisions to the Veterinary Medicines Regulations in Great Britain
Businesses involved in the manufacture, distribution and dispensation of veterinary medicinal products should take the opportunity to respond before the
15/03/2023
Regulatory Outlook
Products | UK Regulatory Outlook February 2023
Medical Technology Strategy | UK to introduce regulatory framework for point of care manufacturing | Commission launches call for evidence
28/02/2023
Regulatory and compliance
UK NHS suppliers required to commit to net zero by 2050 or lose out on future contract opportunities
From April, bidders for NHS contracts over £5 million must produce a carbon reduction plan
20/02/2023
Commercial
Enforcement risks mount in Germany for comparison and intermediary platforms
German watchdog is pursuing misleading behaviour and lack of transparency on ranking, reviews and market coverage
08/02/2023
Life Sciences and Healthcare
Telemedicine in Italy takes next step following pandemic regulatory advance
The 'care relationship' between the physician and the patient will be transformed by telemedicine if not superseded
30/01/2023
Corporate
2023 predictions: What's on the horizon for US businesses operating in Europe?
By staying ahead of the curve and preparing for changes, US businesses can remain competitive and successful in Europe
17/01/2023
Life Sciences and Healthcare
Pharma industry watches as UK Court of Appeal considers issue of plausibility
Decisions to invalidate blood clot drug patents are appealed
13/01/2023
Life Sciences and Healthcare
New year brings healthcare professional interaction rule update in Belgium
The new rules offer more flexibility to life sciences businesses interacting with health professionals and organisations
04/01/2023
Life Sciences and Healthcare
Products without an intended medical purpose: EU clarifies conditions
Non-medical product manufacturers have limited time to prepare for new risk management and clinical data obligations
20/12/2022
Life Sciences and Healthcare
The UK Patents Court puts an arrow through Teva's application for declaratory relief
Court of Appeal makes clear the limits on obtaining Arrow declaratory relief for deployment in other jurisdictions
15/12/2022
